DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 16, 2007; DOI: 10.1124/dmd.107.015503


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.015503v1
35/10/1860    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, K.
Right arrow Articles by Tanaka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, K.
Right arrow Articles by Tanaka, Y.


Received for publication March 12, 2007.
Revised July 11, 2007.
Accepted for publication July 12, 2007.

Lack of Formation of Aldehyde Oxidase Dimer Possibly Due to 377G>A Nucleotide Substitution

Kunio Itoh 1, Hiroaki Maruyama 1, Mayuko Adachi 1, Kouichi Hoshino 1, Nobuaki Watanabe 2, Yorihisa Tanaka 1*

1 Tohoku Pharmaceutical University 2 Sankyo Co. Ltd.

* Address correspondence to: E-mail: ytanaka{at}tohoku-pharm.ac.jp

Abstract

In addition to many papers on marked differences in species and large differences in rat strains in aldehyde oxidase (AO), individual differences in some rat strains have been reported. However, little has been clarified about any related molecular biological mechanisms. We previously revealed that nucleotide substitutions of 377G>A and 2604C>T in the AO gene might be responsible for individual differences of AO in Donryu strain rats. By using native-PAGE/Western blotting in this study, the lack of formation of the AO dimer protein, which is essential for catalytic activity, was shown in poor metabolizer (PM) Donryu rats, and this could be a major reason for the individual differences. Rat strain differences were also verified from the same perspectives of nucleotide substitutions and expression levels of a dimer protein. Rat strains with high AO activity showed nucleotide sequences of (377G, 2604C) and a dimer protein. In cases of those with low AO activity, the nucleotide at position 2604 was fixed at T, but varied at position 377 such as G, G/A, and A. An AO dimer was detected in the liver cytosols of rat strains with (377G, 2604T), whereas a monomer was observed in those with (377A, 2604T). These results suggest that lack of the formation of a dimer protein leading to loss of catalytic activity might be due to 377G>A nucleotide substitution. Individual and strain differences of AO in rats could be explained by this 377G>A substitution, at least in the rat strains used in this study.


Key words: pharmacogenetics, polymorphisms





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.